Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-04

Clinical Trial Update: Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents [Phase 4]

View source ↗

Summary

Phase 4 trial investigating varenicline for nicotine vaping cessation in non-smoker vaper adolescents was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Varenicline (varenicline)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vaping, Nicotine Dependence | Phase 4 | Status: TERMINATED | Results posted: 2024-04-04